Main
>
ONCOLOGY (**)
>
Thyroid Cancer ***
>
Treatment
>
Co: JP. E. Lenvatinib
Co: JP. E. Lenvatinib's subsections
(*) CA; EU; JP; KR Approval
(*) USA Approval Date: 2015. 02.13
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2016. 07.26.
TradeMark
TradeMark Web-Site
Co: JP. E. Lenvatinib's products
This section has no products
(*) CA; EU; JP; KR Approval
(*) USA Approval Date: 2015. 02.13
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2016. 07.26.
TradeMark
TradeMark Web-Site